Fermenta Biotech has reported strong Q1FY26 consolidated financial results.

Net profit soared to INR 21.6 Cr, a significant turnaround from a INR 5.9 Cr loss last year.

Revenue climbed 79% year-over-year to INR 145 Cr, while EBITDA jumped 922% to INR 37 Cr.

This growth was driven by robust volume expansion in human nutrition (up 83% YoY) and animal nutrition (up 45% YoY). Strategic initiatives include a new environmental solutions subsidiary, a food fortification MoU with NIFTEM-T, and key market approvals, positioning the company for continued growth.